EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐Cell and Bulk RNA Sequencing Highlights Intra‐Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer

Junchao Wu, Ziqi Chen, Wentian Wu, Jiaxuan Qin, Rongfang Zhong, Jialin Meng iD, Yu Yin, Peng Guo, Song Fan iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Junchao Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Single-Cell Analysis, Sequence Analysis, RNA, Genetic Heterogeneity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Anhui Province, Anhui Provincial Key Research and Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is an extremely heterogeneous cancer and is highly prevalent in the older male population. Since intra‐tumour heterogeneity (ITH) commonly results in PCa chemotherapy resistance and recurrence, it is critical to explore its effects on tumour behaviour. Prognostic genes related to ITH were identified, and a signature was constructed using Cox regression analyses and multiple machine learning algorithms. Single‐cell RNA sequencing data extracted from PCa and CRPC samples were analysed via sub‐clustering, pseudotime, cell communication and drug sensitivity approaches to elucidate their function. The oncogenic potential of hub genes was confirmed by immunohistochemistry and cell proliferation assays. An 11‐gene signature underlying a prostate cancer meta‐program (PCMP) was generated by selecting an optimal combination of machine learning methods. Survival assays and multivariate Cox regression analyses conducted in multiple cohorts revealed the superior prognostic value of the PCMP signature. Functional enrichment analyses indicated that it dysregulates the cell cycle. Using trajectory and cell–cell communication analyses, we illustrated that PCMP genes exert oncogenic effects by enhancing the proliferation and oxidative phosphorylation of epithelial cells. Intra‐cellular assays also demonstrated that CENPA and CKS1B had promising malignant potential. In summary, our research not only establishes the association between the PCMP signature and reveals its malignant characteristics, but also deepens our understanding of the mechanisms underlying PCa progression and ITH. It holds promise for the development of targeted therapeutic interventions, thereby offering clinical benefits to patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsSingle-Cell AnalysisSequence Analysis, RNAGenetic HeterogeneityHumansMaleDisease ProgressionGene Expression Regulation, NeoplasticPrognosisBiomarkers, TumorCell ProliferationGene Expression ProfilingTranscriptome

Stichwörter der Autor:innen

cell cycleimmunotherapyintra‐tumour heterogeneityprostate cancersingle‐cell RNA sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Institute of Urology, Anhui Medical University, Hefei, China.
  • Anhui Province Key Laboratory of Urological and Andrological Diseases Research and Medical Transformation, Anhui Medical University, Hefei, China.
  • Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Urology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Jialin Meng, Song Fan

Förderung

  • Natural Science Foundation of Anhui Province
  • Anhui Provincial Key Research and Development Plan

Zitieren

APA

Wu, J., Chen, Z., Wu, W., Qin, J., Zhong, R., Meng, J., Yin, Y., Guo, P., & Fan, S. (2025). Single‐Cell and Bulk RNA Sequencing Highlights Intra‐Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70806

Vancouver

Wu J, Chen Z, Wu W, Qin J, Zhong R, Meng J, et al. Single‐Cell and Bulk RNA Sequencing Highlights Intra‐Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70806

BibTeX
@article{Wu2025,
  author = {Wu, Junchao and Chen, Ziqi and Wu, Wentian and Qin, Jiaxuan and Zhong, Rongfang and Meng, Jialin and Yin, Yu and Guo, Peng and Fan, Song},
  title = {Single‐Cell and Bulk RNA Sequencing Highlights Intra‐Tumoral Heterogeneity and Malignant Progression Mechanisms in Prostate Cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70806}
}
Kostenlos starten →